ORAFLEX MAY HAVE COMPASSIONATE USE, FDA ACTING COM. NOVITCH TELLS REP. WEISS; FDA REVISING GUIDELINES TO REQUIRE TWO-SPECIES CARCINOGENICITY STUDIES FOR NDA APPROVAL

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".